Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 41

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 41
---
 corporation and the anti-takeover provisions of the Nevada Revised Statutes may discourage, delay or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the date of the transaction in which the person became an interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, our amended and restated certificate of incorporation, as amended (the “Certificate of Incorporation”) and our new Nevada bylaws contain provisions that may make the acquisition of the Company more difficult, including the following:

| ● | our stockholders will only                                                                                                            
 be able to take action at a meeting of stockholders and will not be able to take action by written consent for any matter;            |
| ● | our board of directors                                                                                                                
 is classified into three classes of directors with staggered three-year terms;                                                        |
| ● | a special meeting of our                                                                                                              
 stockholders may only be called by a majority of our board of directors;                                                              |
| ● | advance notice procedures                                                                                                             
 apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders; 
 and                                                                                                                                   |
| ● | certain litigation against                                                                                                            
 us can only be brought in Nevada.                                                                                                     |

These provisions, alone or together, could discourage, delay or prevent a transaction involving a change in control of the Company. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could limit the opportunity for our stockholders to receive a premium for their shares of our Common Stock, and could also affect the price that some investors are willing to pay for our Common Stock.

We may be subject to securities litigation, which is expensive and could divert management attention.

In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management’s attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant liabilities.

<div align='center'>23</div>

FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our stock.

The Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an investment